Schedule 13G ownership disclosure

X4 Pharmaceuticals Inc

Common Stock · CUSIP: 98420X202

Event date: 2026-02-28

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Morgan Stanley

    Shares: 8,884,338 · Class: 10.2%

  • Morgan Stanley Investment Management Inc.

    Shares: 8,884,304 · Class: 10.2%

  • Inception Trust

    Shares: 4,518,236 · Class: 5.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000895421-26-000094
Form type
SCHEDULE 13G/A
Filer
MORGAN STANLEY
CIK
CIK 895421
Filed
Mar 06, 2026
Reporting period
Feb 28, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub